NCT06926959 Tricuspid RegurgitAtion rIsk modeL Study (TRAIL Study)
| NCT ID | NCT06926959 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sun Yat-sen University |
| Condition | Tricuspid Regurgitation |
| Study Type | OBSERVATIONAL |
| Enrollment | 3,000 participants |
| Start Date | 2016-06-15 |
| Primary Completion | 2030-06-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 3,000 participants in total. It began in 2016-06-15 with a primary completion date of 2030-06-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is a multicenter cohort study including patients diagnosed with tricuspid regurgitation during hospitalization. The primary outcome of the study is all-cause death, and the secondary outcome is cardiovascular events. The prognostic risk factors of patients with tricuspid regurgitation are evaluated, and the prognostic models are constructed through the follow-up observation.
Eligibility Criteria
Inclusion Criteria: * Aged over 18 yrs. * Patients diagnosed with tricuspid regurgitation during hospitalization. Exclusion Criteria: * Patients unable to provide informed consent.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06926959 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Tricuspid Regurgitation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06926959 currently recruiting?
Yes, NCT06926959 is actively recruiting participants. Contact the research team at zhuangxd3@mail.sysu.edu.cn for enrollment information.
Where is the NCT06926959 trial being conducted?
This trial is being conducted at Guangzhou, China, Guangzhou, China, Jieyang, China, Shantou, China and 3 additional locations.
Who is sponsoring the NCT06926959 clinical trial?
NCT06926959 is sponsored by Sun Yat-sen University. The trial plans to enroll 3,000 participants.